M. Pender

K. Dear, T. Dwyer, A. Ponsonby, 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

A simple technique for flat osmicating and flat embedding of immunolabelled vibratome sections of the rat spinal cord for light and electron microscopy

M. Pender, Kim B. Nguyen, 1996, Journal of Neuroscience Methods.

Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome

M. Pender, P. Mccombe, A. Sullivan, 2005, Journal of Clinical Neuroscience.

Use of Traditional and Complementary Medical Care by Patients With Multiple Sclerosis in South-East Queensland

M. Pender, P. Mccombe, P. Webb, 2001 .

T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

M. Pender, P. Mccombe, A. Sullivan, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

polyradiculoneuropathy chronic inflammatory demyelinating and protein in patients with Guillain-Barré syndrome T cell reactivity to P0, P2, PMP-22, and myelin basic

M. Pender, P. Mccombe, P. Csurhes, 2005 .

Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis

S. Burrows, M. Pender, P. Csurhes, 2014, Multiple sclerosis.

Improvement in chronic hepatocerebral degeneration following liver transplantation.

J. Chalk, P. Parkin, M. Pender, 1990, Gastroenterology.

Expression of CD 45 RC and Ia Antigen in the Spinal Cord in Acute Experimental Allergic Encephalomyelitis : An Immunocytochemical and Flow Cytometric Study

M. Pender, P. Mccombe, J. Jersey, 2005 .

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis

A. Coulthard, S. Burrows, R. Khanna, 2014, Multiple sclerosis.

Cyclosporin A treatment modulates cytokine mRNA expression by inflammatory cells extracted from the spinal cord of rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein

M. Pender, P. Mccombe, J. Harness, 2001, Journal of the Neurological Sciences.

Rapid entry and downregulation of T cells in the central nervous system during the reinduction of experimental autoimmune encephalomyelitis

M. Pender, C. White, K. Nguyen, 2001, Journal of Neuroimmunology.

Phagocytosis of apoptotic lymphocytes by oligodendrocytes in experimental autoimmune encephalomyelitis

M. Pender, K. Nguyen, M. P. Pender, 1997, Acta Neuropathologica.

Apoptosis of Vβ8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein

M. Pender, P. Mccombe, Z. Tabi, 1996, Journal of the Neurological Sciences.

Neurological signs in inflammatory demyelination

M. Pender, 1993, Annals of neurology.

Letter Neurological Signs in Inflammatory Demyelination

M. Pender, 1993 .

Demyelination and early remyelination in experimental allergic encephalomyelitis passively ransferred with myelin basic protein-sensitized lymphocytes in the Lewis rat

M. Pender, D. Willenborg, K. Nguyen, 1989, Journal of Neuroimmunology.

Trigeminal sensory neuropathy induced by interferon-alpha therapy.

M. Pender, S. Read, D. Crawford, 1995, Australian and New Zealand journal of medicine.

Neuropathological findings in chronic relapsing experimental allergic neuritis induced in the Lewis rat by inoculation with intradural root myelin and treatment with low dose cyclosporin A

M. Pender, P. Mccombe, S. Kreek, 1992, Neuropathology and applied neurobiology.

Demyelination and Nerve Conduction Abnormalities in Acute and Chronic Experimental Allergic Encephalomyelitis in the Lewis Rat

M. Pender, K. Nguyen, G. Yoong, 1990 .

Survival and mitosis of myelinating oligodendrocytes in experimental autoimmune encephalomyelitis: an immunocytochemical study with Rip antibody

M. Pender, K. Nguyen, M. P. Pender, 1999, Acta Neuropathologica.

Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population

R. Lea, L. Griffiths, M. Pender, 2004, Brain Research Bulletin.

Conduction block in the peripheral nervous system in experimental allergic encephalomyelitis

T. Sears, M. Pender, M. P. Pender, 1982, Nature.

Clinical and histological findings in proteolipid protein-induced experimental autoimmune encephalomyelitis (EAE) in the lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens

J. Chalk, M. Pender, P. Mccombe, 1994, Journal of the Neurological Sciences.

Expression of CD45RC and Ia antigen in the spinal cord in acute experimental allergic encephalomyelitis: An immunocytochemical and flow cytometric study

M. Pender, P. Mccombe, J. Jersey, 1992, Journal of the Neurological Sciences.

Epstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?

R. Khanna, M. Pender, 2014, Immunotherapy.

Chemokines and chemokine receptors: potential therapeutic targets in multiple sclerosis.

M. Pender, J. Greer, D. M. Muller, 2004, Current drug targets. Inflammation and allergy.

Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance.

M. Pender, P. Mccombe, K. Nguyen, 1992, Journal of autoimmunity.

Epstein-Barr virus in the multiple sclerosis brain - An evasive culprit.

M. Pender, 2012, Multiple sclerosis and related disorders.

Restoration of conduction in the spinal roots correlates with clinical recovery from experimental autoimmune encephalomyelitis

J. Chalk, M. Pender, P. Mccombe, 1995, Muscle & nerve.

Demyelination of the Peripheral Nervous System Causes Neurologic Signs in Myelin Basic Protein‐Induced Experimental Allergic Encephalomyelitis

M. Pender, 1988, Annals of the New York Academy of Sciences.

Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?

M. Pender, 2009, Brain : a journal of neurology.

Oligodendrocyte apoptosis before immune attack in multiple sclerosis?

M. Pender, 2005, Annals of neurology.

4: Multiple sclerosis

M. Pender, 2000 .

Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.

M. Pender, P. Mccombe, Z. Tabi, 1996, Journal of the neurological sciences.

Restricted diffusion on MR imaging of an acute cerebral lesion

J. Pandian, A. Coulthard, M. Pender, 2008, Journal of Clinical Neuroscience.

An intracranial arteriovenous malformation and palatal myoclonus related to pseudoxanthoma elasticum.

J. Chalk, M. Patterson, M. Pender, 1989, Australian and New Zealand journal of medicine.

The pathophysiology of acute experimental allergic encephalomyelitis induced by whole spinal cord in the Lewis rat

M. Pender, 1988, Journal of the Neurological Sciences.

Conduction block due to demyelination at the ventral root exit zone in experimental allergic encephalomyelitis

M. Pender, 1986, Brain Research.

Activation‐induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance

M. Pender, 1999, Immunology and cell biology.

Acute transverse myelitis after tetanus toxoid vaccination

M. Pender, Stephen J. Read, G. Schapel, 1992, The Lancet.

Associations between Silicone Skin Cast Score, Cumulative Sun Exposure, and Other Factors in the Ausimmune Study: A Multicenter Australian Study

Terence Dwyer, David Williams, Robyn M Lucas, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Connective tissue disease mimicking multiple sclerosis.

J. Chalk, M. Pender, 1989, Australian and New Zealand journal of medicine.

The pathophysiology of acute experimental allergic encephalomyelitis in the rabbit.

T. Sears, M. Pender, 1984, Brain : a journal of neurology.

The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRβ1 chain is associated with the clinical course of multiple sclerosis

M. Pender, J. Greer, J M Greer, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

T-cell apoptosis in human glioblastoma multiforme: Implications for immunotherapy

Michael J. Rist, M. Pender, D. Walker, 2006, Journal of Neuroimmunology.

Higher fish consumption and lower risk of central nervous system demyelination

K. Dear, T. Dwyer, A. Ponsonby, 2019, European Journal of Clinical Nutrition.

Stressful life events and the risk of initial central nervous system demyelination

T. Dwyer, A. Ponsonby, R. Lucas, 2017, Multiple sclerosis.

Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy

S. Burrows, M. Pender, 2014, Clinical & translational immunology.

Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.

M. Pender, P. Mccombe, J. Greer, 2004, Journal of autoimmunity.

Surges of Increased T Cell Reactivity to an Encephalitogenic Region of Myelin Proteolipid Protein Occur More Often in Patients with Multiple Sclerosis Than in Healthy Subjects1

M. Pender, D. Purdie, M. Good, 2000, The Journal of Immunology.

A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein

R. Houghten, M. Pender, M. Good, 1996, Journal of Neuroimmunology.

Latitudinal variation in incidence and type of first central nervous system demyelinating events

K. Dear, T. Dwyer, A. Ponsonby, 2010, Multiple sclerosis.

The occurrence of autoimmune diseases in patients with multiple sclerosis and their families

Robert D. Henderson, M. Pender, R. Henderson, 2000, Journal of Clinical Neuroscience.

Recent advances in the understanding, diagnosis and management of multiple sclerosis.

M. Pender, 1996, Australian and New Zealand journal of medicine.

The effects of prophylactic cyclosporin A on experimental allergic neuritis (EAN) in the Lewis rat. Induction of relapsing EAN using low dose cyclosporin A

M. Pender, P. Mccombe, S. Kreek, 1990, Journal of Neuroimmunology.

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

Gavin Giovannoni, Amit Bar-Or, Lawrence Steinman, 2019, Trends in Molecular Medicine.

Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis—A Possible Cause of Constitutive NF-κB Activation

M. Pender, P. Mccombe, Jun Yan, 2020, Journal of clinical medicine.

An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population

L. Griffiths, M. Pender, J. Mackenzie, 2009, Brain Research.

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis

J. Burrows, S. Burrows, M. Pender, 2017, Clinical & translational immunology.

Spinal cord disease due to melioidosis.

D. Walker, M. Pender, B. Currie, 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Katherine K. Matthews, A. Coulthard, S. Burrows, 2020, JCI insight.

Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient

Terence Dwyer, Anne-Louise Ponsonby, Keith Dear, 2013, The Journal of Steroid Biochemistry and Molecular Biology.

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

Pablo Moscato, Rodney J. Scott, Brian L. Browning, 2009, Nature Genetics.

Familial occurrence of multiple sclerosis with thyroid disease and systemic lupus erythematosus

J. Chalk, M. Pender, P. Mccombe, 1990, Journal of the Neurological Sciences.

Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system

M. Pender, 2007, Journal of Neuroimmunology.

Apoptosis of inflammatory cells in immune control of the nervous system: Role of glia

Michael J. Rist, M. Pender, Michael P. Pender, 2001, Glia.

Hypothesis: bipolar disorder is an Epstein–Barr virus‐driven chronic autoimmune disease – implications for immunotherapy

M. Pender, 2020, Clinical & translational immunology.

Interleukin-6 Gene Promoter-572 C Allele may Play a Role in Rate of Disease Progression in Multiple Sclerosis

Pamela A. McCombe, M. Pender, P. Mccombe, 2012, International journal of molecular sciences.

Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis

M. Pender, J. Greer, B. T. Sadatipour, 1998, Annals of neurology.

Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis

M. Pender, M. Good, P. Mccombe, 2003, Journal of Clinical Neuroscience.

Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia

M. Pender, B. Mowry, D. McLean, 2014, Journal of Neuroimmunology.

Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population

L. Griffiths, M. Pender, J. Mackenzie, 2009, Journal of the Neurological Sciences.

The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: The Ausimmune study

K. Dear, T. Dwyer, A. Ponsonby, 2013, Multiple sclerosis.

Apoptotic elimination of Vβ8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vβ8.2+ encephalitogenic T cells

M. Pender, P. Mccombe, Z. Tabi, 1994 .

Vestibular and ventilatory dysfunction in sensory and autonomic neuropathy associated with primary Sjörgren's syndrome.

M. Pender, P. Mccombe, G. Sheean, 1992, Journal of neurology, neurosurgery, and psychiatry.

Sun Exposure over a Lifetime in Australian Adults from Latitudinally Diverse Regions

T. Dwyer, A. Ponsonby, R. Lucas, 2013, Photochemistry and photobiology.

Autoimmune Neurological Disease

M. Pender, P. Mccombe, 1995 .

Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types

M. Pender, J. Greer, É. Trifilieff, 2020, Frontiers in Immunology.

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy

A. Coulthard, M. Pender, Z. Ioannides, 2021, Frontiers in Neurology.

Occupational exposure and risk of central nervous system demyelination.

K. Dear, T. Dwyer, A. Ponsonby, 2013, American journal of epidemiology.

Baló's concentric sclerosis in a woman from Papua New Guinea

M. Pender, A. Tannenberg, Ja Hulcombe, 1999, Journal of Clinical Neuroscience.

Consistent patterns of clinical and laboratory findings in patients with co-existent autoimmune thyroid disease and autoimmune demyelinating disease in the central nervous system

M. Pender, J. Greer, 2012 .

Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis1

M. Pender, J. Greer, P. Csurhes, 2008, The Journal of Immunology.

PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations

M. Pender, Jun Yan, J. Greer, 2018, Journal of clinical medicine.

Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population

R. Lea, L. Griffiths, M. Pender, 2004, Journal of the Neurological Sciences.

Autoimmune neurological disease: Autoimmune diseases of the neuromuscular junction and other disorders of the motor unit

M. Pender, P. Mccombe, 1995 .

Experimental Autoimmune Encephalomyelitis

M. Pender, 1995 .

Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects

M. Pender, N. Wolfe, Michael P. Pender, 2002, Internal medicine journal.

Sensorimotor peripheral neuropathy in rheumatoid arthritis.

J. Chalk, M. Pender, P. Mccombe, 1991, Clinical and experimental neurology.

Incidence and prevalence of NMOSD in Australia and New Zealand

K. Dear, S. Broadley, J. Lechner-Scott, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

The pathophysiology of chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.

M. Pender, G. P. Stanley, 1991, Brain : a journal of neurology.

Guillain-Barré syndrome and optic neuritis after Mycoplasma pneumoniae infection.

M. Pender, R. Henderson, G. Ohlrich, 1998, Australian and New Zealand journal of medicine.

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Katherine K. Matthews, A. Coulthard, S. Burrows, 2020, JCI insight.

Progressive visual loss: an unusual presentation of multiple sclerosis

M. Pender, Stephen J. Read, J. Harrison, 1996, Journal of Clinical Neuroscience.

A Higher Mediterranean Diet Score, Including Unprocessed Red Meat, Is Associated with Reduced Risk of Central Nervous System Demyelination in a Case-Control Study of Australian Adults.

K. Dear, A. Ponsonby, R. Lucas, 2019, The Journal of nutrition.

Gastroparesis with multiple sclerosis

B. Leggett, M. Pender, Stephen J. Read, 1995, The Lancet.

Blood–brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement

M. Pender, Diane M. Muller, Michael P. Pender, 2005, Journal of Neuroimmunology.

The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?

M. Pender, 2004, Journal of Clinical Neuroscience.

The pathophysiology of myelin basic protein-induced acute experimental allergic encephalomyelitis in the Lewis rat

M. Pender, 1988, Journal of the Neurological Sciences.

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

A. Bar-Or, H. Hartung, L. Steinman, 2021, Trends in Molecular Medicine.

CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis

S. Burrows, M. Pender, P. Csurhes, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

Recent progress in the diagnosis and treatment of multiple sclerosis

M. Pender, 1999, Journal of Clinical Neuroscience.

Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis

P. Foubert, M. Pender, Z. Ioannides, 2021, Multiple sclerosis journal - experimental, translational and clinical.

Immunology of multiple sclerosis

M. Pender, J. Greer, 2007, Current allergy and asthma reports.

CSF testing for multiple sclerosis

M. Pender, 2005, The Lancet Neurology.

Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi‐centre study

K. Dear, T. Dwyer, A. Ponsonby, 2012, Journal of medical imaging and radiation oncology.

Clinical and immunological findings in patients with concurrent MS and autoimmune thyroid disease

M. Pender, K. Tan, J. Greer, 2004 .

Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis

L. Haupt, R. Lea, L. Griffiths, 2006, Brain Research Bulletin.

Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes

S. Burrows, M. Pender, P. Csurhes, 2011, BMC neurology.

Saliva-derived DNA performs well in large-scale, high-density SNP microarray studies

Marilyn, Merriman, Booth, 2017 .

Hypothermia due to an ascending impairment of shivering in hyperacute experimental allergic encephalomyelitis in the Lewis rat

L. A. Hansen, M. Pender, 1989, Journal of the Neurological Sciences.

Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.

M. Pender, J. Greer, 2008, Journal of autoimmunity.

Focal conduction block in the dorsal root ganglion in experimental allergic neuritis

M. Pender, P. Mccombe, G. P. Stanley, 1992, Annals of neurology.

Early‐life hygiene‐related factors affect risk of central nervous system demyelination and asthma differentially

K. Dear, T. Dwyer, A. Ponsonby, 2013, Clinical and experimental immunology.

Cronkhite-Canada syndrome associated with peripheral neuropathy.

J. Chalk, M. Pender, P. Mccombe, 1991, Australian and New Zealand journal of medicine.

Sun exposure and vitamin D are independent risk factors for CNS demyelination

K. Dear, T. Dwyer, A. Ponsonby, 2011, Neurology.

Current and past Epstein-Barr virus infection in risk of initial CNS demyelination

K. Dear, T. Dwyer, A. Ponsonby, 2011, Neurology.

Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function

K. Dear, T. Dwyer, A. Ponsonby, 2006, Multiple sclerosis.

Preliminary safety and efficacy of ATA188, a pre-manufactured, unrelated donor (off-the-shelf, allogeneic) Epstein-Barr virus-targeted T-cell immunotherapy for patients with progressive forms of multiple sclerosis

S. Broadley, P. Foubert, M. Pender, 2019 .

Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis

S. Burrows, M. Pender, A. Lenarczyk, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction

M. Pender, J. Greer, D. M. Muller, 2000, Acta Neuropathologica.

B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: roles of B cell CD95, CD95L and Bcl-2 expression.

M. Pender, C. White, K. Nguyen, 2000, Journal of autoimmunity.

Offspring number, pregnancy, and risk of a first clinical demyelinating event

K. Dear, T. Dwyer, A. Ponsonby, 2012, Neurology.

Higher fish consumption and lower risk of central nervous system demyelination

K. Dear, T. Dwyer, A. Ponsonby, 2019, European Journal of Clinical Nutrition.

Case report Goodpasture's syndrome associated with multiple sclerosis

M. Pender, R. Henderson, R. D. Henderson, 1998, Acta neurologica Scandinavica.

Population attributable fractions and joint effects of key risk factors for multiple sclerosis

T. Dwyer, A. Ponsonby, R. Lucas, 2016, Multiple sclerosis.

Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.

M. Pender, M. Good, P. Mccombe, 1997, Brain : a journal of neurology.

Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95).

M. Pender, P. Mccombe, C. White, 1998, International immunology.

Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?

M. Pender, B. Mowry, J. Greer, 2005, Immunology and cell biology.

Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.

M. Pender, J. Greer, 2008, Journal of autoimmunity.

Latitudinal variation in incidence of first demyclinating events: descriptive analyses of case participants in the Ausimmune Study

K. Dear, T. Dwyer, A. Ponsonby, 2008 .

Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis

M. Pender, P. Mccombe, C. Winterford, 2018, Journal of Neuroimmunology.

Strains of Epstein-Barr virus infecting multiple sclerosis patients

L. Bromham, R. Brennan, J. Burrows, 2010, Multiple sclerosis.

Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population

L. Griffiths, M. Pender, J. Mackenzie, 2009, Journal of the Neurological Sciences.

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Katherine K. Matthews, S. Burrows, Corey Smith, 2018, JCI insight.